However, inhibition of ZDHHC2, ZDHHC3, and ZDHHC7, which are responsible for palmitoylating Foxp3, might reduce the nuclear localization and stability of Foxp3 in both peripheral lymphoid tissues (e.g., spleen, lymph nodes) and tumor-infiltrating Tregs. Here, FOXP3 is linked to neoplasm.